No retraction, correction or concern found when last checked on Oct 21, 2026.
Increase in blood–brain barrier leakage in healthy, older adults
Inge C. M. Verheggen, Joost J. A. de Jong, Martin P. J. van Boxtel and 6 more
GeroScience · 2020
doi:10.1007/s11357-020-00211-2
Abstract
Blood–brain barrier (BBB) breakdown can disrupt nutrient supply and waste removal, which affects neuronal functioning. Currently, dynamic contrast-enhanced (DCE) MRI is the preferred in-vivo method to quantify BBB leakage. Dedicated DCE MRI studies in normal aging individuals are lacking, which could hamper value estimation and interpretation of leakage rate in pathological conditions. Therefore, we applied DCE MRI to investigate the association between BBB disruption and age in a healthy sample. Fifty-seven cognitively and neurologically healthy, middle-aged to older participants (mean age: 66 years, range: 47–91 years) underwent MRI, including DCE MRI with intravenous injection of a gadolinium-based contrast agent. Pharmacokinetic modeling was applied to contrast concentration time-curves to estimate BBB leakage rate in each voxel. Subsequently, leakage rate was calculated in the white and gray matter, and primary (basic sensory and motor functions), secondary (association areas), and tertiary (higher-order cognition) brain regions. A difference in vulnerability to deterioration was expected between these regions, with especially tertiary regions being affected by age. Higher BBB leakage rate was significantly associated with older age in the white and gray matter, and also in tertiary, but not in primary or secondary brain regions. Even in healthy individuals, BBB disruption was stronger in older persons, which suggests BBB disruption is a normal physiologically aging phenomenon. Age-related increase in BBB disruption occurred especially in brain regions most vulnerable to age-related deterioration, which may indicate that BBB disruption is an underlying mechanism of normal age-related decline. Netherlands Trial Register number: NL6358, date of registration: 2017-03-24.
Full text
From PubMed Central, U.S. National Library of Medicine, as current on Oct 21, 2026. Paragraph numbers are ours, so an answer can point at one.
Introduction
Currently, an increasing number of people are reaching older ages (Lutz et al. ), and studies into the causes and prevention of age-related disorders are becoming increasingly important. However, people who age without any overt pathological condition may still experience some degree of age-related decline (Woodruff-Pak ). This decline shows large interindividual differences (Rapp and Amaral ), while it remains unclear what factors determine whether someone will be strongly affected by age or hardly experience any age-related setback. Cerebral microvascular alterations, occurring over time and contributing to blood–brain barrier (BBB) breakdown, could be a promising topic to study in relation to normal age-related decline (Farkas and Luiten; Norton et al. ).
In the cerebral microvasculature, the vessel wall of the small capillaries contains endothelial cells connected by tight junctions, forming the basis of the BBB (Zlokovic ). The BBB separates the blood from the brain parenchyma and regulates the delivery of energy metabolites and nutrients to the neurons, while preventing neurotoxins from entering the brain tissue. The endothelium contains specialized transport systems that allow nutrients to move from the blood to the brain, while waste products are removed in the opposite direction (Montagne et al.; Zhao et al. ). The BBB thereby protects the brain from concentration fluctuations that occur in the blood stream, which is essential for neuronal and synaptic functioning (Zlokovic ).
Endothelial dysfunction, such as impaired endothelial cell proliferation and migration, is one of the cerebral microvascular alterations occurring over time, as studies have found more endothelial dysfunction in elderly individuals (Murugesan et al.; Ungvari et al.; Ungvari et al. ). Also, aging has been associated with nicotinamide adenine dinucleotide (NAD+) deficiency (Csiszar et al.; Gomes et al.; Yoshino et al. ). NAD+ is a coenzyme, enzyme precursor, or substrate involved in cellular proliferation and function, and the regulation of cellular energetics and mitochondrial metabolism (Bonkowski and Sinclair; Gomes et al. ). Age-related NAD+ depletion has been associated with endothelial dysfunction, and restoring the NAD+ levels appears to protect the integrity of the cerebral microvasculature (Csiszar et al.; Kiss et al.; Mills et al.; Tarantini et al.; Zhang et al. ). Thus, NAD+ deficiency affecting endothelial integrity could be an important cerebral microvascular alteration that contributes to BBB disruption over time.
BBB disruption impairs the oxygen and glucose supply, which may produce hypoxia and hypoxia induced inflammation (Fernando et al.; Raja et al. ). Subsequent pathological processes make the brain vulnerable to neuronal dysfunction and could even lead to neurodegeneration (Levit et al. ). Moreover, BBB disruption reduces the clearance of interstitial solutes from the brain and could result in accumulation of toxic waste products, such as amyloid-β (Aβ) in case of Alzheimer’s disease (AD) (Burgmans et al. ). Aβ was found to further impair neurovascular functioning and the cerebral circulation, even before the actual formation of plaques, suggesting that these neurovascular alterations are an early event in the pathological cascade (DiBattista et al.; Iadecola et al.; Niwa et al.; Niwa et al. ). Imaging studies also support that neurovascular dysfunction and BBB disruption occur early in the development of AD (Iturria-Medina et al.; Montagne et al.; Montagne et al.; van de Haar et al. ).
A large meta-analysis has suggested that BBB permeability increases already as part of normal aging (Farrall and Wardlaw ). However, in these studies the blood/CSF albumin ratio was used as biomarker for BBB leakage, which does not differentiate between blood–brain and blood–cerebrospinal fluid leakage and also cannot localize leakage. Nowadays, a more direct method to detect subtle permeability values is dynamic contrast-enhanced (DCE) MRI (Raja et al. ). A gadolinium-based contrast agent is intravenously injected during scanning, to quantify and localize the spread of contrast from the blood plasma to the brain interstitial fluid, which is dependent on the extent of BBB disruption. To distinguish the rapidly circulating component from the slowly extravasating component, dual-time resolution can ideally be applied (Jelescu et al.; van de Haar et al. ). This acquisition technique applies a fast sequence to capture steep signal changes during the initial circulation phase, and a slow sequence during the later leakage phase. Using this technique, significantly larger BBB leakage rate was found in persons with mild cognitive impairment (Wang et al. ), often considered the transition state to AD, and cerebral small vessel disease (Zhang et al. ), the leading cause of vascular dementia (Pantoni ). A recent study even demonstrated that older adults with early cognitive dysfunction had significantly more BBB leakage than individuals showing no cognitive impairment, even in the absence of any neurological or psychiatric condition (Nation et al. ).
These studies suggest that BBB breakdown is part of the normal aging process and occurs even in the absence of neurological disorders. However, DCE MRI studies investigating whether older individuals have stronger BBB disruption, even when these individuals are considered healthy, have not been conducted. The lack of DCE MRI studies in normal aging individuals could hamper the value estimation and interpretation of BBB leakage observed in recent studies on brain pathology. Therefore, we aimed to investigate the association between BBB leakage and age in healthy, middle-aged to older individuals using DCE MRI.
Higher-order brain regions involved in high-level cognition, such as decision making, planning and related executive functions, are the first brain regions to show age-related deterioration (Andrews-Hanna et al. ). After the higher-order brain regions, the association areas are most vulnerable to age-related impairment, while areas involved in primary sensory and motor functions tend to remain robust as a function of normal aging (Casey et al. ). Our first hypothesis was that older age would be associated with higher BBB leakage rate throughout the cerebral white and gray matter. Secondly, with BBB disruption possibly being an underlying mechanism for normal age-related deterioration, we hypothesized that the association between BBB leakage and age will be most clearly present in those regions most affected by aging, which are the higher-order brain regions.
Participants
Fifty-seven participants (mean age: 66 years, age range: 47–91 years) were recruited from participants of the Maastricht Aging Study (MAAS) (Jolles et al. ), in which 1823 people were cognitively followed from 1992 until 2005. Only normal aging individuals, considered healthy, were eligible for participation. In this study, “healthy” was defined as no substantial decrease in global cognition (Mini-Mental State Examination (MMSE; Folstein et al. ) score ≥ 25), no cognitive impairment due to substance abuse, and no great difficulties in performing activities of daily living (Disabilities Assessment of Dementia (DAD; Gélinas et al. ) score ≥ 90%), as well as no major neurological conditions (no diagnosis of dementia, prodromal dementia, mild cognitive impairment or any other psychiatric or neurological disorder, and no major structural brain abnormalities, brain surgery, or brain trauma as known from the medical history). Furthermore, individuals could only be included when they had no contraindications for MRI or use of gadolinium-based contrast agent (sufficiently functioning kidneys as indicated by an estimated Glomerular Filtration Rate (eGFR) > 30 mL/min).
Sample characteristics
For each participant, age and sex were registered. Experienced neuroradiologists visually rated white matter lesion load according to the Fazekas scale (Fazekas et al. ) (W.P.) and brain atrophy using the global cortical atrophy (GCA) scale (Pasquier et al. ) (A.P.), to confirm our sample could be considered neurologically healthy.
Blood pressure was measured twice, and the mean systolic blood pressure was calculated. Weight and height were measured to calculate the body mass index (BMI). Participants were also asked about the occurrence of diabetes and their smoking habits, after which they were classified as diabetic or non-diabetic and smoker or non-smoker. Systolic blood pressure, BMI, diabetes, and smoking habits were taken into consideration as potential confounders, as these factors may influence neurovascular health and BBB integrity (Gustafson et al.; Mazzone et al.; Rapoport; Starr et al. ).
MRI acquisition
Sagittally oriented slices were acquired on a 3-tesla MRI scanner (Achieva TX, Philips Healthcare, Best, The Netherlands) with a 32-channel head coil. The imaging protocol consisted of 3D T1-weighted inversion recovery fast gradient echo (repetition time (TR)/inversion time (TI)/echo time (TE): 8/800/4 ms; flip angle: 8°; cubic voxel size: 1 mm) for anatomical reference, 3D T2-weighted fluid attenuation inversion recovery (FLAIR) (TR/TI/TE: 4800/1650/290 ms; flip angle: 90°; cubic voxel size: 1 mm, no slice gap) for the white matter hyperintensity (WMH) volume, and dual-time resolution dynamic contrast-enhanced (DCE) MRI for the leakage measurement.
Dual-time DCE MRI consisted of two alternating sequences with a saturation prepulse to provide two time resolutions: a fast sequence with a dynamic scan interval of 3.2 s for high temporal resolution to capture the steep signal changes during the initial circulation phase of the contrast agent and a slow sequence with a dynamic scan interval of 30.5 s with lower temporal but higher spatial resolution during the slower leakage phase of the contrast agent (van de Haar et al. ). The fast sequence consisted of 29 volumes (TR/TE/delay time (TD): 5.3/2.5/120 ms; voxel size: 2 × 2 × 5 mm), and the slow sequence consisted of 30 volumes (TR/TE/TD: 5.3/2.5/120 ms; voxel size: 1 × 1 × 2 mm). Before contrast agent administration, scans of both sequences were acquired. Next, during the fast sequence, gadolinium-based contrast agent (0.1 mmol/kg gadobutrol, Gadavist®, Bayer AG, Leverkusen, Germany) was intravenously injected in the antecubital vein (injection rate 3 mL/s, 20 mL saline flush). Beforehand, T1-mapping was performed to enable conversion of tissue signal intensity to contrast agent concentration (Larsson et al. ).
Brain segmentation
WMH volume (cm3) was determined by creating WMH masks on the FLAIR images using the in-house developed, semi-automatic segmentation tool GIANT (Jacobs et al. ). WMH volume was corrected for intracranial volume.
FreeSurfer software (version 6.0.0) was used for automated brain region segmentation (Fischl et al. ), combined with a visual check with manual adjustments (I.C.M.V.). From these segmentations, cortical thickness (mm) and hippocampal volume (cm3) were obtained. We refer to the brain regions involved in primary sensory and motor functions as primary brain regions, to the association areas as secondary brain regions and to the regions for higher-order cognitive functions as tertiary brain regions. The FreeSurfer software subdivides the cerebral cortex according to the Desikan–Killiany atlas (Desikan et al. ). Using this atlas, two brain regions were selected for each of the three classes: for the primary brain regions the precentral and postcentral gyrus, for the secondary brain regions the supramarginal and superior temporal gyrus, and for the tertiary brain regions the orbitofrontal and cingulate cortex (Fig. 1) (Andrews-Hanna et al.; Casey et al. ). For our analyses, total white matter, total gray matter (cortical and deep gray matter and hippocampus), and primary, secondary, and tertiary brain regions were extracted to create tissue masks for each region of interest (ROI) (Fischl et al. ).
DCE MRI processing
For both the fast and slow DCE MRI, a reference image was created using the average of the pre-contrast images in each sequence. The slow DCE MRI data were motion corrected, and the fast DCE MRI data were motion-corrected and co-registered to the slow DCE MRI data using a single transformation. The reference slow DCE MRI was registered on the T1-weighted anatomic reference images, and the inverse of the obtained transformation matrix was used to transform the T1-weighted data, including the primary, secondary, and tertiary brain regions, to slow DCE space.
At least 20 voxels in the superior sagittal sinus were manually selected (I.C.M.V.) to obtain a vascular input function (VIF) for each participant (Jelescu et al.; van de Haar et al. ). Signal-to-concentration conversion was applied to the VIF using in vitro data (diluted MnCl2 stock solution with varying gadobutrol concentrations ranging from 1 to 40 mM and baseline T1 relaxation time comparable to human blood) and in the brain tissue by assuming a linear relationship and using the tissue relaxation time from the T10-map (van de Haar et al. ).
Pharmacokinetic model analyses
Using the participant-specific VIF, the Patlak approach (Patlak et al. ) was used for voxel-wise pharmacokinetic modeling of the contrast agent concentration in brain tissue and blood plasma. The Patlak model was found to be a suitable model for brain tissue and is the most parsimonious, as it assumes no reflux from the brain tissue back to the blood (Cramer and Larsson ).
With this approach, an estimation of the Ki-parameter (min−1) was obtained for each voxel, which gives an indication of the leakage rate from the blood plasma to the brain tissue as a measure of permeability. Histograms of the Ki values in the white and gray matter and primary, secondary, and tertiary brain regions were calculated and corrected for noise (van de Haar et al. ), after which the mean Ki was calculated for each region.
Statistics
The mean Ki values appeared non-normally distributed and were therefore cube root-transformed to obtain a normal distribution. Multiple linear regression was performed with the mean Ki in each ROI as dependent variable and age and sex as predictors to investigate the association between BBB leakage and age while controlling for sex differences. Potential confounders, namely, mean systolic blood pressure, BMI, diabetes, and smoking habits, were also included in subsequent analyses to check whether they altered the results.
As additional post-hoc analyses, the influence of other measures of structural brain integrity, namely, WMH volume, cortical thickness, and hippocampal volume, was investigated. WMH volume values were log-transformed to obtain a normal distribution. Multiple linear regression was performed with Ki in each ROI as dependent variable, while age, sex, one of the brain integrity measures, and the interaction term between this measure and age were included as predictors. A non-significant interaction term was removed to test the significance of main effects.
All statistical analyses used a significance level of p <.05 and were performed with commercial software (SPSS, version 24.0, IBM Corp., Armonk, NY, USA).
Results
The participant characteristics are presented in Table 1, showing high MMSE scores and low Fazekas and GCA ratings.
For each ROI, the median and 25th–75th percentiles of the leakage rate and its association with age are presented in Table 2.
Ki was significantly correlated with age, as older participants had significantly more widespread BBB leakage in the cerebral white matter (β =.306, p =.024) and gray matter (β =.286, p =.035) (Table 2; Fig. 2).
From the three brain region classes, only Ki in the tertiary brain regions was significantly correlated with age (β =.301, p =.023) (Table 2; Fig. 3).
The associations between Ki and age remained significant when adding the potential confounders mean systolic blood pressure, diabetes, BMI, and smoking habits to the regression analysis.
In the white and gray matter, as well as the tertiary brain regions, significant associations between Ki and age disappeared after correction for WMH volume or cortical thickness. However, significant associations did not depend on hippocampal volume, as correcting for hippocampal volume did not affect the results.
Discussion
In this study, we hypothesized that BBB disruption would be associated with age in cognitively and neurologically healthy, middle-aged to older individuals. Our results confirmed this hypothesis, as we found higher BBB leakage rate in older individuals from a healthy group when investigating the total cerebral white and gray matter tissue compartments. Also, we found a significant correlation between BBB leakage and age in the tertiary brain regions, but not in the primary or secondary regions, which confirms that BBB disruption increases with age especially in those regions that are known to be most vulnerable to normal age-related deterioration.
Previous studies have demonstrated that decrease in cerebral blood flow and cortical volume reductions are most pronounced in the tertiary brain regions during aging (Fjell et al.; Martin et al. ), which supports that age-related detrimental processes especially affect tertiary regions. Our study now shows that BBB disruption could be one of these processes and strongly supports the notion that BBB disruption is an underlying mechanism of normal age-related neurophysiological decline.
Previous studies have already demonstrated that white matter integrity loss and cortical thinning are part of the normal aging process (Maniega et al.; Thambisetty et al. ). We now have evidence that BBB disruption increases during normal aging, but this association is largely explained by age-related white matter integrity loss and decrease in cortical thickness. White matter integrity loss, cortical thinning, and BBB disruption all seem to be normal physiological aging phenomena, while hippocampal volume loss is possibly an independent process that might reflect pathology such as found in AD (Wang et al. ). For future studies, it would be interesting to also include a measure of regional cerebral blood flow, to investigate how cerebral blood flow reduction correlates with these other age-related processes.
Gaining more knowledge on increase in BBB leakage during normal aging could improve the interpretation and value estimation of leakage rate in pathological conditions. Previous studies have already associated BBB disruption with neurodegenerative disorders, such as AD. It seems reasonable to assume that the distinction between normal and pathological conditions is not a dichotomous, but a gradual phenomenon, and therefore, normal aging individuals most likely still experience some degree of age-related setback. Our finding that BBB leakage is even higher in older adults within the range of normal aging implies that BBB disruption could be an early event in the pathological cascade that in some individuals may eventually be contributing to a neurodegenerative disorder. To gain even better insight into BBB disruption over the age span, studies should be conducted over a broader age range. Including adults around the ages of 20 and 30 years could yield a reference point for BBB leakage at later ages.
Our study uses a cross-sectional design to investigate whether higher leakage rate is associated with older age, so ideally future studies should conduct measurements over time to see whether BBB leakage actually increases as people age. Only longitudinal studies might give information on causality. White matter pathology might damage the vessel walls and generate BBB disruption. However, not only the WMHs but also their nearby normal-appearing white matter has been found to be more permeable, which disputes this notion and could mean that BBB disruption is an initiating factor of the pathological cascade, which triggers white matter pathology (Hainsworth; Riphagen et al.; Wong et al. ).
One could also argue on how to define normal aging. Normal aging often means usual aging, where individuals still experience some age-related setback typical for their age group and may have comorbid conditions, as long as these conditions do not significantly affect their functioning (Petersen et al.; Schaie ). Our sample for instance had a high mean systolic blood pressure (Table 1). However, these values are not unusual for these age groups (Gaillard et al. ) and might be an overestimation, as anxiety while measurements are conducted might elevate blood pressure (Verdecchia et al. ). Also, correcting for potential confounders, such as high systolic blood pressure and BMI, did not change our results. Ideally, future studies should also investigate the relation between cardiovascular disease, BBB disruption, and age. For instance, heart failure, which may result in increased central venous pressure, has been shown to cause BBB disruption (Fulop et al. ). Moreover, we selected participants from the Maastricht Aging Study, who have participated in this study for 25 years. Participants who are willing and able to participate over such a long period of time are more likely to represent those with an above-average health condition. We were able to find significantly more BBB leakage with older age even within this functionally healthy subsample, and this effect will possibly be even stronger in a more diverse group, so we expect our findings to be relevant for the general aging population.
The integrity of the cerebral vasculature is an important factor in the development of neurodegenerative disorders. Prevention strategies could therefore focus on promoting neurovascular health. Studies are often aimed at the removal of neurotoxic proteins, but also identification of methods to maintain BBB integrity already at an early stage, such as the promising work on restoring NAD+ levels, might eventually help increasing the proportion of people who will age in a healthier fashion.
Conclusion
We found higher BBB leakage rate with older age in healthy individuals, especially in those brain regions most vulnerable to age-related deterioration, which supports the notion that BBB disruption could be an underlying mechanism of normal age-related decline. Promoting neurovascular health and identification of methods to maintain BBB integrity could be a promising avenue to promote healthy aging.
References 70
- 1.
Andrews-Hanna JR, Snyder AZ, Vincent JL, Lustig C, Head D, Raichle Marcus E, Buckner RL. Disruption of large-scale brain systems in advanced aging. Neuron. 2007;56:924-935.
Not in our library10.1016/j.neuron.2007.10.038
- 2.
Bonkowski MS, Sinclair DA. Slowing ageing by design: the rise of NAD+ and sirtuin-activating compounds. Nat Rev Mol Cell Biol. 2016;17:679-690.
Not in our library10.1038/nrm.2016.93
- 3.
Burgmans S, van de Haar HJ, Verhey FR, Backes WH. Amyloid-β interacts with blood-brain barrier function in dementia: a systematic review. J Alzheimers Dis. 2013;35:859-873.
Not in our library10.3233/jad-122155
- 4.
Casey BJ, Tottenham N, Liston C, Durston S. Imaging the developing brain: what have we learned about cognitive development? Trends Cogn Sci. 2005;9:104-110.
Not in our library10.1016/j.tics.2005.01.011
- 5.
Cramer SP, Larsson HB. Accurate determination of blood–brain barrier permeability using dynamic contrast-enhanced T1-weighted MRI: a simulation and in vivo study on healthy subjects and multiple sclerosis patients. J Cereb Blood Flow Metab. 2014;34:1655-1665.
Not in our library10.1038/jcbfm.2014.126
- 6.
Csiszar A, et al. Role of endothelial NAD+ deficiency in age-related vascular dysfunction. Am J Phys Heart Circ Phys. 2019;316:H1253-H1266.
Not in our library10.1152/ajpheart.00039.2019
- 7.
Desikan RS, et al. An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest. Neuroimage. 2006;31:968-980.
Not in our library10.1016/j.neuroimage.2006.01.021
- 8.
DiBattista AM, Sierra F, Masliah E. NIA workshop on senescence in brain aging and Alzheimer’s disease and its related dementias. 2020. Springer.
Not in our library10.1007/s11357-020-00153-9
- 9.
Farkas E, Luiten PG. Cerebral microvascular pathology in aging and Alzheimer’s disease. Prog Neurobiol. 2001;64:575-611.
Not in our library10.1016/s0301-0082(00)00068-x
- 10.
Farrall AJ, Wardlaw JM. Blood–brain barrier: ageing and microvascular disease—systematic review and meta-analysis. Neurobiol Aging. 2009;30:337-352.
Not in our library10.1016/j.neurobiolaging.2007.07.015
- 11.
Fazekas F, Kleinert R, Offenbacher H, Schmidt R, Kleinert G, Payer F, Radner H, Lechner H. Pathologic correlates of incidental MRI white matter signal hyperintensities. Neurology. 1993;43:1683-1689.
Not in our library10.1212/wnl.43.9.1683
- 12.
Fernando MS, et al. White matter lesions in an unselected cohort of the elderly. Stroke. 2006;37:1391-1398.
Not in our library10.1161/01.str.0000221308.94473.14
- 13.
Fischl B, Sereno MI, Dale AM. Cortical surface-based analysis: II: inflation, flattening, and a surface-based coordinate system. NeuroImage. 1999;9:195-207.
Not in our library10.1006/nimg.1998.0396
- 14.
Fjell AM, McEvoy L, Holland D, Dale AM, Walhovd KB. Brain changes in older adults at very low risk for Alzheimer’s sisease. J Neurosci. 2013;33:8237-8242.
Not in our library10.1523/jneurosci.5506-12.2013
- 15.
Folstein MF, Folstein SE, McHugh PR. “Mini-mental state”: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189-198.
Not in our library10.1016/0022-3956(75)90026-6
- 16.
Fulop GA, et al. Cerebral venous congestion promotes blood-brain barrier disruption and neuroinflammation, impairing cognitive function in mice. Geroscience. 2019;41:575-589.
Not in our library10.1007/s11357-019-00110-1
- 17.
Gaillard C, Jolles J, van Boxtel MP, van Es PN, de Leeuw PW. Repeated automatic versus ambulatory blood pressure measurement: the effects of age and sex in a normal ageing population. J Hypertens. 1996;14:31-40.
Not in our library
- 18.
Gélinas I, Gauthier L, McIntyre M, Gauthier S. Development of a functional measure for persons with Alzheimer’s disease: the disability assessment for dementia. Am J Occup Ther. 1999;53:471-481.
Not in our library10.5014/ajot.53.5.471
- 19.
Gomes AP, et al. Declining NAD+ induces a pseudohypoxic state disrupting nuclear-mitochondrial communication during aging. Cell. 2013;155:1624-1638.
Not in our library10.1016/j.cell.2013.11.037
- 20.
Gustafson D, Karlsson C, Skoog I, Rosengren L, Lissner L, Blennow K. Mid-life adiposity factors relate to blood–brain barrier integrity in late life. J Intern Med. 2007;262:643-650.
Not in our library10.1111/j.1365-2796.2007.01869.x
- 21.
Hainsworth A. White matter lesions in cerebral small vessel disease: underperfusion or leaky vessels? Neurology. 2019; 92:10.1212/WNL.0000000000007258.
Not in our library10.1212/wnl.0000000000007258
- 22.
Iadecola C, et al. SOD1 rescues cerebral endothelial dysfunction in mice overexpressing amyloid precursor protein. Nat Neurosci. 1999;2:157.
Not in our library10.1038/5715
- 23.
- 24.
Jacobs HI, Clerx L, Gronenschild EH, Aalten P, Verhey FR. White matter hyperintensities are positively associated with cortical thickness in Alzheimer's disease. J Alzheimers Dis. 2014;39:409-422.
Not in our library10.3233/jad-131232
- 25.
Jelescu IO, Leppert IR, Narayanan S, Araújo D, Arnold DL, Pike GB. Dual-temporal resolution dynamic contrast-enhanced MRI protocol for blood–brain barrier permeability measurement in enhancing multiple sclerosis lesions. J Magn Reson Imaging. 2011;33:1291-1300.
Not in our library10.1002/jmri.22565
- 26.
Jolles J, Houx P, Van Boxtel M, Ponds R. Maastricht aging study: determinants of cognitive aging. Neuropsych Publishers Maastricht. 1995.
Not in our library
- 27.
Kiss T, et al. Nicotinamide mononucleotide (NMN) treatment attenuates oxidative stress and rescues angiogenic capacity in aged cerebromicrovascular endothelial cells: a potential mechanism for the prevention of vascular cognitive impairment. GeroScience. 2019;41:619-630.
Not in our library10.1007/s11357-019-00074-2
- 28.
Larsson HB, Courivaud F, Rostrup E, Hansen AE. Measurement of brain perfusion, blood volume, and blood-brain barrier permeability, using dynamic contrast-enhanced T1-weighted MRI at 3 tesla. Magn Reson Med. 2009;62:1270-1281.
Not in our library10.1002/mrm.22136
- 29.
Levit A, Hachinski V, Whitehead SN. Neurovascular unit dysregulation, white matter disease, and executive dysfunction: the shared triad of vascular cognitive impairment and Alzheimer disease. GeroScience. 2020;1–21.
Not in our library10.1007/s11357-020-00164-6
- 30.
Lutz W, Sanderson W, Scherbov S. The coming acceleration of global population ageing. Nature. 2008;451:716-719.
Not in our library10.1038/nature06516
- 31.
- 32.
Martin AJ, Friston KJ, Colebatch JG, Frackowiak RS. Decreases in regional cerebral blood flow with normal aging. J Cereb Blood Flow Metab. 1991;11:684-689.
Not in our library10.1038/jcbfm.1991.121
- 33.
- 34.
Mills KF, et al. Long-term administration of nicotinamide mononucleotide mitigates age-associated physiological decline in mice. Cell Metab. 2016;24:795-806.
Not in our library10.1016/j.cmet.2016.09.013
- 35.
Montagne A, Barnes SR, Sweeney MD, Halliday MR, Sagare AP, Zhao Z, Toga AW, Jacobs RE, Liu CY, Amezcua L, Harrington MG, Chui HC, Law M, Zlokovic BV. Blood-brain barrier breakdown in the aging human hippocampus. Neuron. 2015;85:296-302.
Not in our library10.1016/j.neuron.2014.12.032
- 36.
Montagne A, Nation DA, Pa J, Sweeney MD, Toga AW, Zlokovic BV. Brain imaging of neurovascular dysfunction in Alzheimer’s disease. Acta Neuropathol. 2016;131:687-707.
Not in our library10.1007/s00401-016-1570-0
- 37.
Montagne A, Zhao Z, Zlokovic BV. Alzheimer’s disease: a matter of blood–brain barrier dysfunction? J Exp Med. 2017;214:3151-3169.
Not in our library10.1084/jem.20171406
- 38.
Murugesan N, Demarest TG, Madri JA, Pachter JS. Brain regional angiogenic potential at the neurovascular unit during normal aging. Neurobiol Aging. 2012;33:1004. e1001-1004. e1016.
Not in our library10.1016/j.neurobiolaging.2011.09.022
- 39.
Nation DA, et al. Blood–brain barrier breakdown is an early biomarker of human cognitive dysfunction. Nat Med. 2019; doi:10.1038/s41591-018-0297-y.
Not in our library10.1038/s41591-018-0297-y
- 40.
Niwa K, Kazama K, Younkin L, Younkin SG, Carlson GA, Iadecola C. Cerebrovascular autoregulation is profoundly impaired in mice overexpressing amyloid precursor protein. Am J Phys Heart Circ Phys. 2002;283:H315-H323.
Not in our library10.1152/ajpheart.00022.2002
Cited by papers we hold 4
- Brain macrophage development, diversity and dysregulation in health and disease · 2023No notice
- Microbial-derived metabolites as a risk factor of age-related cognitive decline and dementia · 2022No notice
- Blood–Brain Barrier Breakdown: An Emerging Biomarker of Cognitive Impairment in Normal Aging and Dementia · 2021No notice
- The blood–brain barrier in systemic infection and inflammation · 2021No notice
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.